Search Results - "KOUTROUBAKIS, IOANNIS E."

Refine Results
  1. 1

    Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis by Rokkas, Theodore, Portincasa, Piero, Koutroubakis, Ioannis E

    “…Fecal calprotectin (FC) has been suggested as a sensitive biomarker of inflammatory bowel disease (IBD). However, its usefulness in assessing IBD activity…”
    Get full text
    Journal Article
  2. 2

    Multipotent role of platelets in inflammatory bowel diseases:A clinical approach by Voudoukis, Evangelos, Karmiris, Konstantinos, Koutroubakis, Ioannis E

    Published in World journal of gastroenterology : WJG (28-03-2014)
    “…There is evidence that inflammatory bowel diseases(IBD)combine both inflammation and coagulation in their pathogenesis and clinical manifestations.Although…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Ischemic colitis: clinical practice in diagnosis and treatment by Theodoropoulou, Angeliki, Koutroubakis, Ioannis-E

    Published in World journal of gastroenterology : WJG (28-12-2008)
    “…Ischemic colitis is the most common form of ischemic injury of the gastrointestinal tract and can present either as an occlusive or a non-occlusive form. It…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Increased Serum Apelin Levels in Patients with Inflammatory Bowel Disease by Mantaka, Aikaterini, Kalyvianaki, Konstantina, Kastritsi, Olga, Kampa, Marilena, Koutroubakis, Ioannis E.

    Published in Gastroenterology insights (01-06-2024)
    “…Apelin has been implicated in the pathogenesis of several chronic inflammatory diseases through mechanisms related to endothelial cells dysfunction. There is…”
    Get full text
    Journal Article
  7. 7

    Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease by Karmiris, Konstantinos, Koutroubakis, Ioannis E, Xidakis, Costas, Polychronaki, Maria, Voudouri, Theodora, Kouroumalis, Elias A

    Published in Inflammatory bowel diseases (01-02-2006)
    “…Background: There is evidence that adipocytokines play an important role in metabolism and in inflammation. Because human metabolism dramatically changes in…”
    Get full text
    Journal Article
  8. 8

    Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis? by Mantaka, Aikaterini, Galanakis, Nikolaos, Tsetis, Dimitrios, Koutroubakis, Ioannis E.

    Published in Intestinal research (01-10-2022)
    “…Background/Aims: Abdominal aortic calcium (AAC) deposition has been suggested as a marker of early atherosclerosis. There is no published data on the…”
    Get full text
    Journal Article
  9. 9

    Thrombosis and inflammatory bowel disease-the role of genetic risk factors by Tsiolakidou, Georgia, Koutroubakis, Ioannis-E

    Published in World journal of gastroenterology : WJG (28-07-2008)
    “…Thromboembolism is a significant cause of morbidity and mortality in patients with inflammatory bowel disease (IBD). Recent data suggest thromboembolism as a…”
    Get full text
    Journal Article
  10. 10

    Etiology of Anemia and Risk Factors of Mortality among Hospitalized Patients: A Real-Life Retrospective Study in a Tertiary Center in Greece by Ioannou, Petros, Papazachariou, Andria, Tsafaridou, Maria, Koutroubakis, Ioannis E, Kofteridis, Diamantis P

    Published in Hematology reports (02-06-2023)
    “…Anemia is a prominent global health issue with a wide variety of causes and can be associated with decreased quality of life, increased hospitalization, and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease? by Theodoraki, Eirini, Orfanoudaki, Eleni, Foteinogiannopoulou, Kalliopi, Legaki, Evangelia, Gazouli, Maria, Koutroubakis, Ioannis E.

    Published in Intestinal research (01-10-2021)
    “…Background/Aims: The measurement of infliximab trough levels (IFX-TLs) in patients with inflammatory bowel disease (IBD) is performed to optimize treatment…”
    Get full text
    Journal Article
  14. 14

    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease by Theodoraki, Eirini, Orfanoudaki, Eleni, Foteinogiannopoulou, Kalliopi, Koutroubakis, Ioannis E

    Published in Inflammatory bowel diseases (18-05-2018)
    “…Abstract Background Both muscle-related complaints and elevated serum creatine kinase (CK) levels have been reported in patients with inflammatory bowel…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Stimulating erythropoiesis in inflammatory bowel disease associated anemia by Tsiolakidou, Georgia, Koutroubakis, Ioannis-E

    Published in World journal of gastroenterology : WJG (28-09-2007)
    “…Anemia is a frequent complication in patients with inflammatory bowel disease (IBD), and is associated with decreased quality of life and increased rate of…”
    Get full text
    Journal Article
  17. 17

    Spectrum of non-inflammatory bowel disease and non-infectious colitis by Koutroubakis, Ioannis-E

    Published in World journal of gastroenterology : WJG (28-12-2008)
    “…A variety of inflammatory diseases of the colon, which can be differentiated from inflammatory bowel disease (IBD) and infectious colitis by their clinical,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Role of scintigraphy in inflammatory bowel disease by Stathaki, Maria I, Koukouraki, Sophia I, Karkavitsas, Nikolaos S, Koutroubakis, Ioannis E

    Published in World journal of gastroenterology : WJG (14-06-2009)
    “…The diagnosis of inflammatory bowel disease (IBD) depends on direct endoscopic visualization of the colonic and ileal mucosa and the histological study of the…”
    Get full text
    Journal Article
  20. 20